• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library

    Alpha Tau Fills Pivotal Skin Cancer Trial, Eyes FDA DaRT Approval

    GLOBENEWSWIRE

    BMS Wins EU Approval for Sotyktu in Active Psoriatic Arthritis

    PHARMIWEB

    Inhibrx to Host Webcast on INBRX-106 HexAgon First-Line HNSCC

    PR NEWSWIRE

    FDA Approves Ocrevus for Pediatric Relapsing-Remitting MS

    FIRSTWORD PHARMA

    Leqembi-Iqlik PDUFA Date Updated To August 24 In US

    PR NEWSWIRE

    Neuland, LIR Partner to Advance Cell Penetrating Peptide Platform

    EXPRESSPHARMA

    Immunai and AstraZeneca Expand AI-Driven Biomarker Project

    AI JOURNAL

    EnGene`s Shares Crash On Updated Pivotal Bladder Cancer Data

    ENDPOINTS

    GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs

    PR NEWSWIRE

    Atara, Pierre`s Cell Therapy to Get Another Shot at FDA Approval

    BIOSPACE

    Jaguar Health Regains Nasdaq Compliance, Gets Bid Price Extension

    PHARMIWEB

    ENvue Medical Wins USPTO Nod for Ultrasound-Enhanced CBD Delivery

    GLOBENEWSWIRE

    Liver-Targeted Gene Clears Brain Amyloid, Sparks Alzheimer`s Hope

    FIERCE BIOTECH

    Oblique Therapeutics Names Dr. Jan Lundberg as Scientific Advisor

    PR NEWSWIRE

    FDA Issues Guidance on Pregnancy Safety Data for Drugs, Biologics

    FDA

    Illumina Shows Multi-Omics Potential for Precision Medicine India

    INDPHARMAPOST

    Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore

    INDPHARMAPOST

    Atossa Therapeutics Reports Q1 2026 Results and Corporate Update

    PR NEWSWIRE

    Spectral Medical Unveils Q1 2026 Financials And Corporate Update

    GLOBENEWSWIRE

    Two Singaporeans Test Negative for Hantavirus After Cruise Scare

    REUTERS

    Avicanna Announces Results of Annual General and Special Meeting

    GLOBENEWSWIRE

    Longeveron Has Positive FDA Type C Meeting Before ELPIS II Data

    GLOBENEWSWIRE

    Cytokinetics Closes $805M Public Offering With Full Underwriter

    GLOBENEWSWIRE

    Vistagen Completes PALISADE-4 Phase 3 Dosing for Social Anxiety

    PHARMIWEB

    Reg T Cell Therapy Reshapes Organ Transplant Tolerance Paradigm

    FIRSTWORD PHARMA

    argenx Wins FDA Nod to Expand VYVGART to All Adult gMG Patients

    GLOBENEWSWIRE

    bioAffinity Reports Q1 2026 Results and Growing CyPath Lung Use

    PHARMIWEB

    Moleculin Biotech Wins New Patent to Strengthen Annamycin Reach

    GLOBENEWSWIRE

    Entera Reports Q1 2026 Results and Oral Peptide Program Updates

    GLOBENEWSWIRE

    Allarity CEO to Present at Precision Medicine Forum Europe 2026

    GLOBENEWSWIRE

    Tvardi Therapeutics Reports Q1 2026 Results and Business Update

    GLOBENEWSWIRE

    Pharvaris Prices $115M Underwritten Offering of Ordinary Shares

    GLOBENEWSWIRE

    Fulcrum Therapeutics Issues Inducement Grants Under Nasdaq Rule

    GLOBENEWSWIRE

    Genflow Biosciences Announces Warrant Exercise and Equity Issue

    PHARMIWEB

    Alamar Biosciences Reports First Quarter 2026 Financial Results

    GLOBENEWSWIRE

    Azalea Shows First-in-Primate In Vivo TRAC-CAR T Data at ASGCT

    GLOBENEWSWIRE

    AAVnerGene Unveils AAVone 2.1 Next-Gen AAV Production Platform

    PR NEWSWIRE

    Artiva Biotherapeutics Prices $300M Stock and Warrant Offering

    GLOBENEWSWIRE

    Femasys Reports Q1 2026 Financial Results and Corporate Update

    GLOBENEWSWIRE

    IV Tenecteplase Before EVT Shows Promise in Late-Window Stroke

    FIRSTWORD PHARMA

    India Monitors Cruise Ship Hantavirus Outbreak, No Local Cases

    ECONOMICTIMES

    Integra LifeSciences to Present at BofA 2026 Health Conference

    GLOBENEWSWIRE

    FDA Finalizes CMC Flexibility Guidance for Cell Gene Therapies

    RAPS

    Sanofi India, NHM MP Partner to Boost NCD, Rare Disease Access

    INDPHARMAPOST

    Leniobio, Twist Bioscience Partner On AI Drug Discovery Models

    CONTRACTPHARMA

    Trump Plans To Fire Makary From FDA Role, According To Reports

    ENDPOINTS

    TOMI Reports Q1 2026 Results, Eyes Merger With Carbonium Core

    GLOBENEWSWIRE

    Day One, Servier Complete FIREFLY-2 Enrollment for pLGG Trial

    PR NEWSWIRE

    Kanvas Biosciences Funded to Develop Maternal Microbiome Drug

    FIRSTWORD PHARMA

    Judge Weighs CMS CBD Program as Medicare Outpaces FDA Science

    PHARMIWEB

    Biofrontera to Report Q1 2026 Results and Host Call on May 14

    GLOBENEWSWIRE

    Humacyte to Report Q1 2026 Results and Business Update May 13

    GLOBENEWSWIRE

    ANI Pharma Reports Q1 2026 Results, Raises Full-Year Guidance

    GLOBENEWSWIRE

    Artiva Biotherapeutics Reports Q1 2026 Results and Highlights

    GLOBENEWSWIRE

    Odyssey Nears $900M Valuation as Shares Surge on Nasdaq Debut

    REUTERS

    Arcutis Biotherapeutics Issues Inducement Grants Under Nasdaq

    GLOBENEWSWIRE

    Oregon Campaign Brings Independent Pharmacies Back Into Focus

    PR NEWSWIRE

    Tenax Therapeutics Issues Inducement Grants Under Nasdaq Rule

    GLOBENEWSWIRE

    Ocular Therapeutix Issues Inducement Grants Under Nasdaq Rule

    GLOBENEWSWIRE

    InflaRx Closes $150M Underwritten Offering of Ordinary Shares

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.